StockWatch
·

LUMAX AUTO TECHNOLOGIES LTD. Q2 FY27 Results

LUMAXTECHQ2 FY27 Results
Filing
Result:Very Good· Market: Down#Record quarter#Margin expansion#Broad based

Beat/Miss: Beat · Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue1.6K14.1%34.5%
Total Income1.6K14.2%34.3%
Expenditure1.4K13.9%33.0%
PBT154.2416.8%47.8%
Net Profit116.6718.3%50.4%
OPM13.47%0.48pp0.11pp
NPM7.41%0.26pp0.79pp
EPS15.4821.8%57.8%
View full financials

Revenue (+34.5% YoY) and PAT (+50.4% YoY) both beat the street with margins expanding YoY (NPM 6.62%→7.41%, OPM 13.36%→13.47%) on a clean base with no one-offs, though sequential EBITDA margin softness (Q1's 15.1% to ~14.7%) vs management's own guidance tempers an otherwise standout quarter.

LUMAX AUTO TECHNOLOGIES LTD. · QQ2 FY-2027 · THE CALL

Record growth masks margin compression and deceleration ahead

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

03 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Q2 numbers matched guidance closely (₹1,556 Cr vs ₹1,555.5 delivered). EBITDA margin guidance (prior 15.1%) not formally lowered but compressed to 14.7%, margin recovery dependent on assumption.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Lumax delivered 35% revenue growth and 50% PAT growth in Q2, exceeding many expectations, driven by Mechatronics momentum and strong order visibility. However, EBITDA margin compressed 20 bps QoQ to 14.7% despite pricing actions, and management guided H2 growth to 15–20% (decelerating from H1's 34%), signalling cost inflation absorption challenges and demand moderation. Long-term 20% CAGR to ₹11,000 Cr has concrete capex backing (₹300 Cr FY27, new Mechatronics plant, Greenfield), but near-term margin recovery is uncertain and LIL/Aftermarket remain soft.

₹1555.5 Cr

Revenue · +34.5% YoY

₹116.7 Cr

Reported PAT · +50.4% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Q2 FY27 revenue ₹1,556 Cr, up 35% YoY

MET

Delivered ₹1,555.5 Cr, up 34.5% YoY

Q2 PAT ₹117 Cr, up 50% YoY

MET

Delivered ₹116.7 Cr, up 50.4% YoY

Q2 EBITDA ₹228 Cr at 14.7% margin, stable QoQ

OVERSTATED

Q2 reported OPM 13.5%, NPM 7.4%; Q1 margin 14.9%, implies QoQ decline

Aftermarket grew 9% YoY in H1

MET

Aftermarket revenue H1 FY27 ₹234 Cr vs H1 FY26 ₹216 Cr = 8.3% growth, below historical pace

H2 FY27 growth expected 15–20% YoY

Unverified

Implied guidance, lower than H1 34% delivered; suggests deceleration ahead

Earnings quality

What changed since the last call

Deltas vs. the prior call

Mechatronics acceleration & new plant capex

Upgrade

Prior call: Mechatronics 22% EBITDA contribution. Now: 27% of order book, ₹150 Cr new plant capex approved for Manesar. Expected ₹500 Cr post-commission revenue at scale, vs implied ₹1,000–1,100 Cr by FY31 (material upgrade in scale ambition).

Margin guidance QoQ compression

Downgrade

Prior Q1 call: 15.1% EBITDA margin guidance. Q2 delivered 14.7%, down 20 bps QoQ. Management reaffirmed 14.7% is 'broadly stable' but H2 margin recovery assumed, not proven.

H2 revenue growth deceleration guidance

Downgrade

H1 delivered 34% growth; management guided H2 to 15–20% YoY growth, a significant moderation, citing higher base and macro headwinds.

Aftermarket growth weakness

Downgrade

Aftermarket 9% growth in H1 vs prior double-digit growth. Input costs and demand softness cited; management expects 'modest improvement' but 15–20% growth target (not 20%+ prior expectation).

The Q&A

Analysts pressed hard on guidance revision (Amit Hiranandani: 'Are we revising upward after 34% growth?'). Management held firm: 20–25% FY27 full-year growth, no upward revision. Several probed margin sustainability and timing of cost recovery (Raksha Srivastava, Apurva Mehta); management detailed max 1-quarter lag and claimed confidence in full recovery. Deep Shah questioned North Star guidance consistency; management clarified FY25 base and reaffirmed 20% CAGR achievable organically. Overall, management held guidance despite strong delivery, suggesting cautious outlook on sustainability.

The exchanges that mattered

Guidance revision post-growth — Amit Hiranandani, PhillipCapital

Dodged

No, we expect full-year 20–25% growth (₹6,000 Cr implied). H1 25% growth, H2 will moderate due to higher base from FY26.

Mechatronics content per vehicle — Radha, Motilal Oswal

Partial

Currently ₹70,000–₹75,000 per PV across product portfolio. Expected to grow by ~10% over 2–3 years as new products scale.

Cost pass-through timing — Raksha Srivastava, Narnolia Financial Services

Answered

Most recoveries happen same quarter or max 1Q lag. Showing 30–40 bps margin dilution due to lag. Confident to recover in subsequent quarters.

North Star CAGR guidance clarity — Deep Shah, New Vernon Capital

Answered

20% CAGR is from FY25 base. For FY27, 20–25% expected. Industry growing 12–15%; we outperform. If we inorganic, CAGR exceeds 20%.

Mechatronics margin trajectory — Apurva Mehta, AM Investments

Answered

Mechatronics margins currently in line with Lumax overall (14–15%). Long-term aspiration 15–18% as scale reaches critical mass and fixed costs absorb.

BCM orders and OEM identity — Amit Hiranandani, PhillipCapital

Partial

₹250 Cr order book locked. Technology from large Japanese auto-component maker (not OEM). Standalone revenue, all profitability stays with Lumax.

Guidance

Forward guidance and management's confidence

FY27 full-year: 20–25% YoY growth expected (from implied ₹6,000 Cr base of FY26 ₹5,000 Cr)

Medium

H1 delivered 34% growth; H2 expected 15–20% due to higher comparison base and macro uncertainty. Management guided to 20–25% at year start.

H2 FY27: 15–20% YoY growth (moderation from H1 34%)

Medium

Higher base from FY26 H2 growth; supply-chain inflation expected to persist; demand momentum will be key monitor.

FY31 (long-term): ₹11,000 Cr revenue (20% CAGR from FY25 base of ~₹3,000 Cr)

Low

Aspiration target. Requires 20% CAGR for 6 years; dependent on organic growth (claimed 15% achievable) plus inorganic (5–7% assumed).

FY27: EBITDA margin ~14.7% (no formal revised guidance, but QoQ showed 14.9% → 14.7% compression)

Medium

Prior call guided 15.1%; current quarter 14.7%. Margin recovery dependent on assumption of full cost pass-through to OEMs in subsequent quarters.

FY28: Absolute EBITDA ₹1,000 Cr (implies ~15% margin if 6,500–6,700 Cr revenue assumed)

Medium

Management confident of FY28 EBITDA guidance. Margin recovery in FY28 contingent on cost stability and Mechatronics scaling.

Long-term (FY31): Target ~20% EBITDA margin (range 17–20% mentioned)

Low

Aspiration. Requires structural margin expansion as Mechatronics and high-margin new products scale (BCM, EV components). No binding commitment.

FY27 capex: ₹300 Cr (H1 ₹60 Cr incurred; remaining ₹240 Cr in H2)

High

Allocation: Mechatronics Manesar plant (~₹150 Cr), Greenfield Nashik ferrule-less expansion, IAC capacity.

Risks the call surfaced

Ranked by how much they should concern a holder

Margin recovery timing

High

EBITDA margin compressed 20 bps QoQ (14.9% to 14.7%) despite claimed cost pass-through. Management cites max 1Q lag, but recovery unproven. If delayed beyond Q3, full-year margin guidance at risk.

Customer concentration

High

Advanced Plastics is 44% of ₹1,879 Cr order book. OEM concentration risk (passenger vehicle segment). If PV demand slows or a major OEM reduces orders, material revenue impact.

Aftermarket demand softness

Medium

Aftermarket grew only 9% in H1 FY27 vs prior double-digit growth. Input cost headwinds and softening replacement demand cited. If trend persists, will weigh on overall growth and profitability.

Mechatronics execution risk

Medium

₹150 Cr capex approved for new Manesar Mechatronics plant; SOP expected H2 FY28 with ₹500 Cr peak revenue potential. Delays or cost overruns could derail FY28–FY29 revenue and margin targets.

EV product strategy uncertainty

Medium

EV component strategy narrowed to 3–5 product categories. No major OEM wins or confirmed orders disclosed. If market adoption slower than expected or competition intense, revenue ramp could be delayed.

Management

Score 7/10. Clear on strategy and numbers; transparent on segment performance and challenges (Aftermarket weakness, cost pressures). Evasive on BCM partner identity and BCM product details. Some deflection when pressed on guidance upward revisions. Strong H1 FY27 delivery: 34% revenue growth, 50% PAT growth. Guided FY27 to 20–25%, implying moderation. FY28 ₹1,000 Cr EBITDA target stated with confidence but unproven. Margin recovery track record weak (14.7% vs 15.1% prior guidance).

What to watch next
  • 1 · Q3 FY27

    Greenfuel ferrule-less tubes production ramp for Mahindra/Maruti CNG vehicles

  • 2 · H2 FY28

    Mechatronics Manesar plant SOP; BCM (Body Control Module) production scale-up from Japanese partner

  • 3 · FY28

    FY28 EBITDA ₹1,000 Cr (absolute) guidance to be tested; margin recovery assumption

Long-term 20% CAGR to ₹11,000 Cr has concrete capex backing (₹300 Cr FY27, new Mechatronics plant, Greenfield), but near-term margin recovery is uncertain and LIL/Aftermarket remain soft.

Informational and educational content only. Not investment advice.